Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/28/2012CN102391367A Plant stress-tolerance-relative protein, coding gene thereof, and application thereof
03/28/2012CN102391366A Preparation method of chicken infectious bronchitis virus HA antigen
03/28/2012CN102391198A Melamine caproic acid and preparation method and use thereof
03/28/2012CN101921779B Gene DvCRP2 with Cd2+ resistant and Cu2+ resistant functions, encoding protein and application thereof
03/28/2012CN101747425B Protein relevant to retina photoreaction as well as coding gene and applications thereof
03/28/2012CN101724029B Anti-tumor protein and preparation method and application thereof
03/28/2012CN101693893B Ammonia transport protein gene, protein coded by same and application thereof
03/28/2012CN101659698B Violacein synthesized related protein system, coding gene cluster thereof and application thereof
03/28/2012CN101624420B Group of novel cyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof
03/28/2012CN101619095B Preparation method of soybean polysaccharide protein in soybean dregs
03/28/2012CN101531712B Bt protein Cry30Bal as well as encoding gene thereof and application thereof
03/28/2012CN101230101B Recombinant protein used as NT-proBNP immunodiagnosis reagent standard as well as preparation method and use thereof
03/28/2012CN101090973B Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby
03/27/2012US8143477 All-native recombinant plant
03/27/2012US8143381 Use of ionic liquids for membrane protein extraction
03/27/2012US8143376 High affinity NY-ESO T cell receptor
03/27/2012US8143372 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
03/27/2012US8143224 Oxidant resistant apolipoprotein A-1 and mimetic peptides
03/27/2012US8143222 Modular platform for targeted therapeutic delivery
03/27/2012US8143214 Protein-polymer conjugates
03/27/2012US8143211 Bioactive peptides
03/27/2012US8143058 Human CDR-grafted antibody and antibody fragment thereof
03/27/2012US8143056 Vascular adhesion molecules and modulation of their function
03/27/2012US8143054 Fusion protein of HIV regulatory/accessory proteins
03/27/2012US8143027 Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity
03/27/2012US8143026 Albumin fusion proteins
03/27/2012US8143016 Methods of cleaving DNA with rationally-designed meganucleases
03/27/2012US8143015 Methods of cleaving DNA with rationally-designed meganucleases
03/27/2012US8143011 MAGE-C2 antigenic peptides and uses thereof
03/27/2012US8143010 Prostate-specific polypeptide PAMP and encoding nucleic acid molecules
03/27/2012US8143005 Nucleic acids encoding sodium channel SCN1A alpha subunit proteins and mutations associated with epilepsy
03/27/2012US8142797 Therapeutic TB vaccine
03/27/2012US8142794 Hepatitis C virus vaccine
03/27/2012US8142791 Multi-modal cancer therapy using viral hitch-hiking
03/27/2012US8142790 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
03/27/2012US8142781 Fusion proteins for blood-brain barrier delivery
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142764 Synthetic biofilm-inhibiting peptides
03/27/2012CA2603671C Insp163 polypeptides for the treatment or prevention of cancer and arthritis
03/27/2012CA2584482C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
03/27/2012CA2554968C Process for screening glycoform-specific antibodies
03/27/2012CA2534224C Preparation of somatostatin peptides
03/27/2012CA2521784C Reversible pegylated drugs
03/27/2012CA2486109C No-apical meristem proteins, polynucleotides and methods of use for same
03/27/2012CA2485698C Peptide amidation process
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2435812C Process and compositions for peptide, protein and peptidomimetic synthesis
03/27/2012CA2433792C Enterohemorragic escherichia coli vaccine
03/27/2012CA2421087C Antisense insulin-like growth factor binding protein (igfbp)-2 oligodeoxynucleotides for prostate and other endocrine tumor therapy
03/27/2012CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
03/27/2012CA2378497C Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
03/27/2012CA2329250C Peptide antiangiogenic drugs
03/27/2012CA2309903C Nucleic acid sequences encoding capsaicin receptor
03/27/2012CA2287545C Ma family polypeptides and anti-ma antibodies
03/27/2012CA2245496C Receptor protein designated 2f1
03/22/2012WO2012037397A2 Step-derived peptide for brain injury treatment
03/22/2012WO2012037370A1 Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
03/22/2012WO2012037215A2 Recombinant yeast with improved ethanol tolerance and related methods of use
03/22/2012WO2012037199A2 Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles
03/22/2012WO2012037015A2 Novel lactobacillus salivarius and novel bacteriocin
03/22/2012WO2012036884A2 Bioproduction of aromatic chemicals from lignin-derived compounds
03/22/2012WO2012036551A1 Total chemical synthesis of ubiquitin, ubiquitin mutants and derivatives thereof
03/22/2012WO2012036410A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
03/22/2012WO2012036140A1 Affinity carrier for refining or removing protein or peptide having kringle sequence, and refinement method and removal method in which affinity carrier is used
03/22/2012WO2012036094A1 Lung cancer identification marker
03/22/2012WO2012035869A1 Method for extracting undenatured type ii collagen having active epitope
03/22/2012WO2012035518A1 Compositions and methods for treatment of drug resistant multiple myeloma
03/22/2012WO2012035120A2 Screening method
03/22/2012WO2012035115A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/22/2012WO2012035103A1 Lysozymes
03/22/2012WO2012035088A1 Na+/Mg2+ exchanger
03/22/2012WO2012035066A1 Hot1 and uses thereof
03/22/2012WO2012035050A2 Factor viii variants having a decreased cellular uptake
03/22/2012WO2012035034A1 Serpin-finger fusion polypeptide
03/22/2012WO2012034532A1 Hereditary spinocerebellar ataxia-related gene and use thereof
03/22/2012WO2012034188A1 Peptide inhibitors of cd40l signaling and uses therefor
03/22/2012WO2012013617A3 Polymeric complements to b-amyloid peptides
03/22/2012WO2011161551A3 Omv (outer membrane vesicle) vaccines
03/22/2012WO2011159882A3 Novel stabilized insulin agonists
03/22/2012WO2011145915A3 Modified polyhedrin, and polyhedras and biotechnological products obtained from same
03/22/2012WO2011142858A9 Chlorotoxin variants, conjugates, and methods for their use
03/22/2012WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells
03/22/2012US20120073023 Novel gene regulating tillering and leaf morphology in plant and utilization of the same
03/22/2012US20120073010 Plants and seeds of sorghum variety gsv958220
03/22/2012US20120071637 Selective enrichment of antibodies
03/22/2012US20120071636 Risperidone immunoassay
03/22/2012US20120071632 Lenalidomide and Thalidomide Immunoassays
03/22/2012US20120071631 Isolation and Characterization of Novel Green Fluorescent Proteins from Copepods
03/22/2012US20120071630 Nucleic Acid and Amino Acid Sequences of Infectious Salmon Anaemia Virus and Their Use as Vaccines
03/22/2012US20120071629 Appoptosin and uses thereof for treating neurodegenerative disease and cancer
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071422 Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor
03/22/2012US20120071419 Target-Specific Non-Antibody Protein and Method for Preparing the Same
03/22/2012US20120071415 Dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma)
03/22/2012US20120071406 Modified vegf-a with improved angiogenic properties
03/22/2012US20120071402 Protease Stabilized, Pegylated Insulin Analogues
03/22/2012US20120071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120071393 Mutant CyaA Polypeptides and Polypeptide Derivatives Suitable for the Delivery of Immunogenic Molecules Into a Cell
03/22/2012US20120071334 Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 2916